Fish oil

Last updated: May 6, 2025

Fish oil, rich in omega-3 fatty acids like EPA and DHA, is derived from the tissues of oily sea fish and has been a part of human diets, particularly in coastal populations, for centuries, with scientific interest growing significantly since observations in the late 1970s. These fatty acids are incorporated into cell membranes throughout the body and are precursors to signaling molecules that can reduce inflammation, improve blood lipid profiles, and support brain and heart health. Studies suggest fish oil may offer benefits for mood, particularly in elderly individuals with depression, and can positively influence cardiovascular risk factors, though evidence for preventing major cardiovascular events is mixed.

Categories & Effectiveness
Dosage & Side Effects
Benefits by Use Case
Mechanism of Action
Frequently Asked Questions
Summary & Expert Opinion
Research Studies

Back to All Nootropics

Categories & Effectiveness

Brain Health

Neuro-Repair Support

4/10

Moderate evidence of effectiveness

Cognition

Visual Enhancement

4/10

Moderate evidence of effectiveness

Mood & Stress

Mood Elevation

4/10

Moderate evidence of effectiveness

Systemic Health

Anti-Inflammatory (Systemic)

7/10

Strong evidence of effectiveness

Blood Pressure Regulation

4/10

Moderate evidence of effectiveness

Cellular Repair

4/10

Moderate evidence of effectiveness

Vascular Health

4/10

Moderate evidence of effectiveness

Dosage & Side Effects

Recommended Dosage

Commonly recommended doses for adults range from 1 to 4 grams of combined EPA and DHA per day, depending on the intended health benefit. While an optimal dose is not definitively established, daily intakes up to 5 grams are generally considered safe, though higher doses (above 1 g/day) may carry increased risks for certain conditions like atrial fibrillation. Pregnant women have used doses from 0.2 to 4 g/day for specific benefits, and elderly individuals in depression studies have taken an average of 1.3 g/day.

Potential Side Effects

Common mild side effects of fish oil supplementation include gastrointestinal issues such as fishy aftertaste, burping, nausea, diarrhea, and abdominal discomfort. High doses or chronic use may lead to a mild increase in bleeding tendency, and some studies suggest high doses (>1 g/day) could potentially increase the risk of atrial fibrillation. Individuals with digestive disorders, bleeding disorders, or those taking anticoagulant medications should use fish oil with caution and consult their healthcare provider.

Bioavailability & Half-Life

Omega-3 fatty acids EPA and DHA from fish oil are absorbed in the small intestine, with their incorporation into tissues and blood cells occurring over hours to days; taking supplements with a fatty meal can enhance absorption. The metabolic pathway involves desaturation and elongation enzymes if starting from alpha-linolenic acid (ALA), but EPA and DHA from fish oil are directly utilized or further metabolized by cyclooxygenase (COX), lipoxygenase (LOX), and cytochrome P450 (CYP450) enzyme systems into various bioactive lipid mediators. The elimination half-life of EPA and DHA from plasma can vary, but they are incorporated into cell membranes for longer periods, contributing to their sustained effects; specific pharmacokinetic values like peak plasma time and precise half-life can differ based on the formulation (e.g., ethyl esters vs. triglycerides vs. free fatty acids) and individual metabolism.

Interactions & Stacks

Fish oil is often stacked with statins, where it may provide synergistic effects in managing cholesterol levels and reducing atherosclerotic plaque progression. Caution is advised when combining high doses of fish oil with anticoagulant or antiplatelet medications due to a potential, though generally mild, increased risk of bleeding. Meta-analyses and user consensus indicate mixed results for cardiovascular event prevention, with benefits appearing to be dose-dependent and specific to certain populations or formulations (e.g., EPA-only).

Benefits by Use Case

Cardiovascular Health Support

May help reduce triglyceride levels and blood pressure, and has anti-inflammatory effects relevant to heart health. However, its effectiveness in preventing major cardiovascular events like heart attacks or strokes shows inconsistent results in large clinical trials.

Mood Enhancement (Depression)

Can reduce symptoms of depressed mood, particularly in elderly individuals with mild to moderate depression, with EPA often highlighted for this benefit. It is generally not shown to be effective for improving mood in healthy individuals or preventing depression.

Anti-inflammatory Effects

Reduces the production of inflammatory eicosanoids and cytokines, potentially benefiting conditions with an inflammatory component. The clinical significance of this effect can vary widely depending on the specific condition and dosage used.

Retinal Health & Neuroprotection

Animal studies suggest omega-3s can offer neuroprotection in the retina by reducing apoptosis and inflammation. Human clinical data for specific eye conditions like autosomal dominant optic atrophy is still emerging.

Mechanism of Action

Fish oil's primary active components, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are incorporated into the phospholipids of cell membranes, altering membrane fluidity and the function of membrane-bound proteins. They serve as substrates for cyclooxygenase (COX), lipoxygenase (LOX), and cytochrome P450 (CYP450) enzymes, leading to the production of a range of lipid mediators. Unlike arachidonic acid (an omega-6 fatty acid) which produces largely pro-inflammatory eicosanoids (e.g., prostaglandin E2, thromboxane A2, leukotriene B4), EPA and DHA are converted into less inflammatory or anti-inflammatory eicosanoids, as well as specialized pro-resolving mediators (SPMs) like resolvins, protectins, and maresins, which actively orchestrate the resolution of inflammation. These fatty acids can also influence gene expression, for instance, by activating peroxisome proliferator-activated receptors (PPARs) which regulate lipid metabolism and inflammation, and by decreasing the activity of sterol receptor element-binding protein-1c (SREBP-1c) to reduce triglyceride synthesis. In cardiac cells, omega-3s can modulate ion channel activity (e.g., sodium and calcium channels), potentially stabilizing cardiomyocyte electrical activity.

Frequently Asked Questions

Is fish oil good for my heart?

Can fish oil help with depression?

What's the best dose of fish oil?

Are there side effects to fish oil?

When should I take fish oil?

Does fish oil interact with medications?

Is EPA or DHA more important?

Can fish oil help lower cholesterol?

Summary & Expert Opinion

Fish oil, a source of omega-3 fatty acids EPA and DHA, is widely recognized for its potential to support cardiovascular health by improving lipid profiles and reducing inflammation, and for its benefits in mood disorders, particularly depression in the elderly. Its strengths lie in its anti-inflammatory actions and triglyceride-lowering effects, but limitations include inconsistent results from large clinical trials regarding the prevention of major cardiovascular events and potential side effects like gastrointestinal upset or increased atrial fibrillation risk at high doses. Individuals looking to support their mood (especially elderly individuals with mild to moderate depression), manage elevated triglycerides, or generally increase their omega-3 intake may consider fish oil, ideally after consulting a healthcare professional. Those with bleeding disorders, on anticoagulant therapy, or with a history or high risk of atrial fibrillation should exercise caution, especially with higher doses, and discuss use with their doctor.

Research Studies

Showing 5 of 7 studies

A Systematic Review of Omega-3 Fatty Acid Consumption and Cognitive Outcomes in Neurodevelopment (2022)

Authors:

Dean Sherzai

Participants:

Humans during the period of neurodevelopment: from fetal development to adolescence.

Study Quality Assessment:

Systematic review evaluating articles published between 2000 and 2022.

Fish oil and omega-3 fatty acids in cardiovascular disease: do they really work? (2012)

atrial fibrillation cardiovascular disease coronary heart disease +2 more

Findings:

This systematic review concludes that while basic research suggests multiple cardioprotective mechanisms for fish oil (ω-3 PUFAs like EPA and DHA), clinical evidence from numerous studies (RCTs, meta-analyses) regarding its efficacy in preventing or treating cardiovascular diseases (hypertension, CHD, AF, HF) is inconsistent and controversial. Potential benefits appear influenced by dose, formulation (EPA vs. EPA+DHA), patient population, baseline ω-3 status, and background therapy, with high doses (>1 g/d) potentially increasing atrial fibrillation risk. Further research is needed to clarify optimal use and mechanisms.

Participants:

Systematic review discussing studies involving in vitro/in vivo models (e.g., rats, mice) and diverse human populations including healthy subjects, individuals with CVD risk factors (hypertension, dyslipidemia, diabetes, obesity), patients with established CVD (CHD, MI, AF, HF), specific groups (children, pregnant women, elderly), and post-surgical/procedural patients (CABG, PCI, cardioversion).

Dosage:

Discusses a wide range of dosages from reviewed studies: low dose (≤1 g/day, e.g., 400mg, 840mg, 1g) and high dose (>1 g/day, e.g., 1.8g, 2g, 2.4g, 3.6g, 4g, up to 10g loading dose). Mentions specific formulations (purified EPA like icosapent ethyl, EPA+DHA combinations as ethyl esters or carboxylic acids) and ratios (e.g., EPA:DHA 6:1, 1:1, 1:2, <1). Notes potential dose-dependent effects (e.g., BP reduction, AF risk, biomarker changes), but optimal dose remains undefined.

Study Quality Assessment:

Systematic review summarizing evidence from basic research (in vivo/in vitro), Randomized Controlled Trials (RCTs), cohort studies (prospective, cross-sectional), and meta-analyses. Discusses methodological factors influencing results of cited studies, including dosage (low: ≤1 g/d vs. high: >1 g/d), formulation (EPA vs. EPA+DHA, ethyl ester vs. carboxylic acid), placebo type (mineral oil, corn oil, olive oil), baseline ω-3 levels, background medical therapy (e.g., statins, antiplatelets), study duration, and specific methods (e.g., 24h BP monitoring, plaque imaging). Acknowledges controversial results and limitations in the evidence base. Funding source for the review is mentioned.

All Effects:

atrial fibrillation cardiovascular disease coronary heart disease heart failure hypertension

An 18-mo randomized, double-blind, placebo-controlled trial of DHA-rich fish oil to prevent age-related cognitive decline in cognitively normal older adults

APOE-ε4 interaction cognitive performance oxidative stress +2 more

Findings:

Daily supplementation with 2.3 g DHA-rich fish oil for 18 months did not maintain or improve cognitive performance in cognitively healthy older adults. A small negative main effect was observed on psychomotor speed, and treatment effects differed by sex and APOE-ε4 status on some cognitive domains. Treatment was also associated with increased perceived cognitive mistakes and increased oxidative stress.

Participants:

Cognitively healthy Australian community-dwelling adults (aged 65-90 y), N=403 randomly assigned, N=390 analyzed (intervention n=194, control n=196).

Dosage:

1720 mg DHA and 600 mg eicosapentaenoic acid (total 2.3 g DHA-rich fish oil) daily for 18 months.

Study Quality Assessment:

18-month randomized, double-blind, placebo-controlled, parallel-group trial. Permuted-block randomization stratified by age. Cognitive assessments conducted at baseline and every 6 months. Primary analyses used latent growth curve models. Secondary outcomes included self-reported well-being/functioning, blood pressure, biomarkers (n-3 LC PUFAs, lipids, glucose metabolism, inflammation, oxidative stress, DNA damage), and Mini-Mental State Examination. Sample size N=390 analyzed. Trial registered (ACTRN12607000278437).

All Effects:

APOE-ε4 interaction cognitive performance oxidative stress psychomotor speed sex differences

Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis.

depressed mood depression treatment

Omega-3 fatty acids promote neuroprotection, decreased apoptosis and reduced glial cell activation in the retina of a mouse model of OPA1-related autosomal dominant optic atrophy

apoptosis reduction glial cell activation reduction neuroprotection +2 more

Findings:

Omega-3 PUFA supplementation (EPA/DHA 5:1 ratio) showed neuroprotective effects in the retinas of both Opa1enu/+ and wild-type mice. This included increased retinal ganglion cell and ON axonal densities, reduced apoptosis (decreased Caspase-3 and Bax expression), and decreased activation of inflammatory microglia and astrocytes. Neuroprotection did not appear related to oxidative stress inhibition (no change in SOD-2 expression).

Participants:

Animal model: Eight-month-old mice (Opa1enu/+ and wild-type strains), n=20 per group.

Dosage:

EPA and docosahexaenoic acid (DHA) in a 5:1 ratio administered by daily gavage for 4 months. Dosage was adjusted based on maintaining a blood arachidonic acid (AA) to eicosapentaenoic acid (EPA) ratio (AA/EPA) between 1.0-1.5.

Study Quality Assessment:

Study design involved four groups (n=20/group). Methods included daily gavage administration, blood level monitoring (AA/EPA ratio), gas chromatography for fatty acid levels, histological examination of retina and optic nerve (ON), Western blotting, and immunohistochemistry. Funding source mentioned: Research Support, Non-U.S. Gov't.

All Effects:

apoptosis reduction glial cell activation reduction neuroprotection optic nerve health retinal health

Pilot, Randomized, Double-Blind, Crossover Study of Fish Oil [Epa and Dha] Fo ... memory in HIV-1-infected men.

DHA EPA biomarker uptake +1 more

Findings:

Erythrocyte EPA+DHA composition increased in the fish oil (FO) groups (p = 0.0001). Participants successfully reduced background consumption of EPA, DHA, and anthocyanins as prescribed.

Participants:

elderly men and women

Dosage:

Daily administration (specific amount not mentioned)

Study Quality Assessment:

24-week randomized, double blind, placebo-controlled trial. Diet records confirmed participant adherence.

All Effects:

DHA EPA biomarker uptake fish oil

Systematic review and meta-analysis of omega-3-fatty acids in elderly patients with depression.

depressed mood depression elderly +2 more

Findings:

Omega-3 PUFA supplementation showed no significant effect on depressed mood compared to placebo in the 'well-being mental health' elderly group. However, it demonstrated a large, significant effect in reducing depressed mood in the 'depressive group', specifically noted as effective in elderly patients with mild to moderate depression.

Participants:

N=4605 elderly patients (mean age 76.97 years, older than 65 years, male-female ratio=3752:853) with depression. Analysis separated participants into a 'well-being mental health group' and a 'depressive group'.

Dosage:

Mean dose across included studies: 1.3 g/d.

Study Quality Assessment:

Systematic review and meta-analysis of 6 randomized control trials (N=4605 total patients). Seven databases searched up to September 2016. Statistical analysis used Hedges g, 95% confidence intervals, and a random-effects model.

All Effects:

depressed mood depression elderly mental health omega-3 fatty acids

We value your privacy

Categories & Effectiveness

Brain Health

Neuro-Repair Support

Cognition

Visual Enhancement

Mood & Stress

Mood Elevation

Systemic Health

Anti-Inflammatory (Systemic)

Blood Pressure Regulation

Cellular Repair

Vascular Health

Dosage & Side Effects

Recommended Dosage

Potential Side Effects

Bioavailability & Half-Life

Interactions & Stacks

Benefits by Use Case

Cardiovascular Health Support

Mood Enhancement (Depression)

Anti-inflammatory Effects

Retinal Health & Neuroprotection

Mechanism of Action

Frequently Asked Questions

Summary & Expert Opinion

Research Studies

A Systematic Review of Omega-3 Fatty Acid Consumption and Cognitive Outcomes in Neurodevelopment (2022)

Authors:

Participants:

Study Quality Assessment:

Fish oil and omega-3 fatty acids in cardiovascular disease: do they really work? (2012)

Findings:

Participants:

Dosage:

Study Quality Assessment:

All Effects:

An 18-mo randomized, double-blind, placebo-controlled trial of DHA-rich fish oil to prevent age-related cognitive decline in cognitively normal older adults

Findings:

Participants:

Dosage:

Study Quality Assessment:

All Effects:

Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis.

Findings:

Study Quality Assessment:

Omega-3 fatty acids promote neuroprotection, decreased apoptosis and reduced glial cell activation in the retina of a mouse model of OPA1-related autosomal dominant optic atrophy

Findings:

Participants:

Dosage:

Study Quality Assessment:

All Effects:

Pilot, Randomized, Double-Blind, Crossover Study of Fish Oil [Epa and Dha] Fo ... memory in HIV-1-infected men.

Findings:

Participants:

Dosage:

Study Quality Assessment:

All Effects:

Systematic review and meta-analysis of omega-3-fatty acids in elderly patients with depression.

Findings:

Participants:

Dosage:

Study Quality Assessment:

All Effects:

Similar Nootropics

Berberine

Holy Basil

L-Theanine

Pentoxifylline